ARWR - Arrowhead Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARWR is currently covered by 7 analysts with an average price target of $56.01. This is a potential upside of $20.6 (58.18%) from yesterday's end of day stock price of $35.41.

Arrowhead Pharmaceuticals's activity chart (see below) currently has 245 price targets and 190 ratings on display. The stock rating distribution of ARWR is 89.47% BUY and 10.53% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.98% with an average time for these price targets to be met of 256.95 days.

Highest price target for ARWR is $80, Lowest price target is $17, average price target is $45.86.

Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 10-Aug-2025. First documented stock forecast 04-Mar-2014.

Currently out of the existing stock ratings of ARWR, 17 are a BUY (89.47%), 2 are a HOLD (10.53%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$60

$23.88 (66.11%)

$60

2 months ago
(10-Aug-2025)

4/21 (19.05%)

$42.79 (248.63%)

193

Buy

$80

$43.88 (121.48%)

$80

4 months 21 days ago
(19-May-2025)

0/22 (0%)

$63.71 (391.10%)

Buy

$40

$3.88 (10.74%)

$42

4 months 28 days ago
(12-May-2025)

2/11 (18.18%)

$24.72 (161.78%)

100

Hold

$17

$-19.12 (-52.93%)

$26

4 months 28 days ago
(12-May-2025)

5/6 (83.33%)

$1.72 (11.26%)

54

Buy

$38

$1.88 (5.20%)

$55

7 months 27 days ago
(13-Feb-2025)

8/16 (50%)

$18.05 (90.48%)

135

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?

On average it took 256.95 days on average for the stock forecasts to be realized with a an average price target met ratio 65.98

Which analyst has the current highest performing score on ARWR (Arrowhead Pharmaceuticals) with a proven track record?

LUCA ISSI

Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?

Luca Issi works at RBC and has 4 price targets and 3 ratings on ARWR

Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?

Esther Rajavelu with highest potential upside - $65.88

Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?

Shawn Egan with lowest potential downside - -$19.12

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?